News Summary: Court backs FDA in Cytori case

News Summary: Appeals court backs FDA in rejecting fast-track approval for Cytori devices

Associated Press

SHORT CIRCUIT: A federal appeals court said that the Food and Drug Administration made the right call in rejecting fast-track approval of two Cytori Therapeutics Inc. devices used to process adult stem cells.

SPIN DOCTORS: Cytori devices separate adult stem cells from fat tissue with a combination of spinning and chemical reactions. The company appealed an FDA decision in 2011 that said it needed a more rigorous approval process.

REWIND: Cytori has begun a large study it will use to seek traditional FDA approval. It will evaluate stem cell injections as a treatment for patients with heart disease.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.